Myomo (MYO) Total Non-Current Liabilities (2016 - 2025)

Myomo's (MYO) quarterly Total Non-Current Liabilities came in at $25.6 million in Q4 2025, up 509.38% on a QoQ basis from $4.2 million in Q3 2021.

Myomo (MYO) Total Non-Current Liabilities (2016 - 2025) Analysis & Trends

Myomo (MYO) has 7 years of Total Non-Current Liabilities data on file, last reported at $25.6 million in Q4 2025.

Quarterly Total Non-Current Liabilities changed N/A year-over-year to $25.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.6 million (changed N/A YoY) and the FY2025 annual result came in at $25.6 million, changed N/A from the prior year.
Total Non-Current Liabilities rose to $25.6 million in Q4 2025, from $4.2 million in the prior quarter.
In the past five years, Total Non-Current Liabilities ranged from a high of $25.6 million in Q4 2025 to a low of $3.8 million in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Non-Current Liabilities (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	-
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	21.28 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	40.90 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	42.74 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	2.57 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	3.68 Bn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	23.89 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	9.07 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	3.44 Bn
10	Myomo	67.26 Mn	48.29 Mn	-	24.58 Mn

Download Data